-

OXM Investor Alert: Levi & Korsinsky Investigates Oxford Industries, Inc. (OXM) for Potential Securities Fraud

Oxford Industries guided investors toward a $1.50 billion revenue midpoint while undisclosed cost pressures and tariff exposure were already eroding the outlook -- then cut guidance to $1.49 billion, sending OXM down 17%.

NEW YORK--(BUSINESS WIRE)--Shareholders who held Oxford Industries, Inc. (NYSE: OXM) stock lost approximately 17% of their investment value when the company slashed its FY 2026 revenue guidance midpoint to $1.49 billion and projected Q2 sales roughly 5.8% below Wall Street consensus estimates. Those who lost money on OXM are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Oxford Industries maintained a FY 2026 revenue guidance midpoint of $1.50 billion through its public communications. The revised FY 2026 guidance lowered revenue guidance midpoint to $1.49 billion and Q2 outlook of approximately $390 million and represented a material reduction from figures investors had relied upon.

Shareholders who suffered losses on their Oxford Industries investment are encouraged to click here to discuss their legal rights with Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com

Frequently Asked Questions About the OXM Investigation

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Oxford Industries made materially false or misleading statements regarding its FY 2026 revenue guidance and the underlying cost pressures and tariff exposure that were not reflected in public guidance figures. When the revised outlook was disclosed, the stock price declined 17%.

Q: When did Oxford Industries allegedly mislead investors? A: The investigation focuses on statements made during the period when Oxford Industries maintained its original FY 2026 revenue guidance midpoint of $1.50 billion through public filings and earnings communications, prior to the corrective disclosure that sent the stock lower.

Q: What do OXM investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What if I already sold my OXM shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought OXM and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

Q: How long will the investigation take to resolve? A: Securities fraud investigations typically take two to four years from initiation to resolution.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NYSE:OXM

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

CAPR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Capricor (CAPR)

NEW YORK--(BUSINESS WIRE)--Capricor (NASDAQ: CAPR) shares collapsed 60% to 70% on July 27, 2026 after FDA staff briefing documents raised significant concerns regarding the evidence supporting Deramiocel's efficacy ahead of the July 29, 2026 advisory committee meeting. CAPR shareholders who saw their investment drop after the FDA briefing documents are encouraged to act promptly. To respond while the investigation is active, submit your CAPR loss information or contact Levi & Korsinsky, LLP...

WIX Shareholder Alert: Wix.com Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors in Wix.com Ltd. (NASDAQ: WIX) that a securities class action has been filed on behalf of shareholders who purchased WIX securities between February 19, 2025 and May 12, 2026. Learn more about the case. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.WIX shares declined from $181.74 on May 20, 2025, to $55.32 after the alleged corrective sequence across a period of six separate alleged c...

CCOI Shareholder Alert: COGENT COMMUNICATIONS HOLDINGS, INC. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors in Cogent Communications Holdings, Inc. (NASDAQ: CCOI) that a class action has been filed on behalf of shareholders who purchased securities between February 29, 2024 and May 1, 2026. Submit your information now. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.CCOI allegedly declined from more than $86.00 in November 2024 to less than $17.00 after the Class Period, a drop of more than 8...
Back to Newsroom